Affordable Access

An extended two-year trial of lamivudine in Chinese patients with chronic hepatitis B.

Authors
Type
Published Article
Journal
Chinese medical journal
Publication Date
Volume
115
Issue
12
Pages
1814–1818
Identifiers
PMID: 12622930
Source
Medline
License
Unknown

Abstract

Sustained HBV replication and clinical improvement could be obtained by the long-term lamivudine therapy with good tolerance and safety.

Statistics

Seen <100 times